InvestorsHub Logo
Followers 43
Posts 5448
Boards Moderated 0
Alias Born 11/15/2013

Re: meds4life post# 388298

Saturday, 12/03/2022 10:32:22 AM

Saturday, December 03, 2022 10:32:22 AM

Post# of 463723
Exactly, here's what they all saw and it's as crisp and clear as a cold December morning. Huge news.

ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS,

SHOWING STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN GLOBAL CLINICAL STUDY OF PATIENTS WITH EARLY ALZHEIMER’S DISEASE

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News